Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
Forums
Psychedelics
Psychedelic Medicat...
Psychedelic Trials ...
 
Notifications
Clear all

Psychedelic Trials Are Effectively Open-Label. The FDA Has to Decide What to Do With That.

 
Psychedelic Medication
Last Post by Anonymous 2 weeks ago
1 Posts
1 Users
0 Reactions
28 Views
Solved
RSS
 Dr. Ramirez
(@Dr. Ramirez)
Joined: 3 months ago
Posts: 26
Topic starter 02/06/2026 9:01 am  

COMPASS Pathways received FDA Breakthrough Therapy designation for its psilocybin therapy COMP360 for treatment-resistant depression in October 2018.

https://www.clinicaltrialvanguard.com/opinion/psychedelic-trials-are-effectively-open-label-the-fda-has-to-decide-what-to-do-with-that/



   
Quote
Topic Tags
psychedelic psilocybin psychedelic trials trials effectively effectively open

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  psychedelic (121) , psilocybin (370) , psychedelic trials (1) , trials effectively (1) , effectively open (1) ,